TheEl genusénero Malachra L. bpertelongs to thenece a la familyia Malvaceae. It includes herbs or subshrubs of nine accepted ncluye hierbas o subarbustos de nueve especies with apaceptadas con aproximately thirty synonyms, and it has been widely used in community folk medicine to treat healthadamente treinta sinónimos, y ha sido ampliamente utilizado en la medicina popular comunitaria para tratar problems includingas de salud que incluyen inflammation, nasal mación, obstructioncción nasal, leishmaniasis, malaria, childbirth, kidney disorders, fever,parto, trastornos renales, fiebre, enfermedades del tracto respiratory tract diseases, among otherio, entre otros. otros.
Malachra species | Plant Part Used | Phytoconstituents | Reference | ||||
---|---|---|---|---|---|---|---|
Malachra alceifolia Jacq. | Leaf | Flavonoids, steroids, triterpenes anthocyanins, leucoanthocyanins, saponins |
[9][22] | ||||
Flowers | Flavonoids, steroids, triterpenes anthocyanins, leucoanthocyanins |
||||||
Malachra capitata (L.) L. | Root | Gallic acid (1), caffeic acid (2), rutin (3), quercetin (4), ferulic acid (5) | [10][11][23,24] | ||||
Leaf | Rutin, ferulic acid | ||||||
Stem | Gallic acid | ||||||
Whole plant | β-Sitosterol (6) | [12][25] | |||||
Root | Carbohydrates, phenols, flavonoids, glycosides, triterpenes, alkaloids, tannins, saponins | [10][11][23,24] | |||||
ratas Wistar | In vivo | oral administration to Wistar rats pylorus ligated model, 50mg/kg, p.o ranitidine controlInhibir la acumulación de productos de peroxidación lipídica, actividades de superóxido dismutasa y catalasa |
[34][ 73 ] | Root | |||
Aqcueouoso | Tetradecanoic acid, ethyl ester (7); | Hepatoprotectivehepatoprotector | [10][11][23,24] | ||||
100, 200 y 400 mg/kg | In vivo | oral administration to Wistar rats, carbon tetrachloride CCl4 induced hepatotoxicityAdministración oral in vivo a ratas Wistar, hepatotoxicidad inducida por tetracloruro de carbono CCl 4 |
RNiveles reduced levels of theidos de las enzimas hepáticas SGOT, SGPT, fosfatasa alcalina (ALP) y hepfosfatic enzymes SGOT, SGPT, alkaline phosphatase (ALP), and acid phosphatase (ACP) asa ácida (ACP) |
[35][ 74 ] | linolenic acid, ethyl ester (8); | ||
LNanopartículas deaf silver nanoparticles (AgNPs) hoja de plata (AgNP) |
n-hexaneo | Aantibacterialno | 1 mMm | In vitro MICCIM in vitro |
Nanopartiícleulas bactericidas bactericidal Bacillus subtillis, Micrococcus Luteus, Staphylococcus aureus and Pseudomonas Bacillus subtillisaeruginosa , Micrococcus Luteus, Staphylococcus aureus y Pseudomonas aeruginosa |
[36][ 75 ] | (E)-11-hexadecenoic acid, ethyl ester (9); |
LeHojaf | Mmethanolicanólico, Chloroform Benzene cloroformo benceno |
Aantibacterialno | 50 mg/mLl | In vitro MICCIM in vitro |
Inhibitcion of thón del crecimiento de growth of Escherichia coli, Escherichia coli Listeria monocytogenes Listeria monocytogenes |
[37][ 76 ] | hexadecanoic acid, ethyl ester (10); |
octadecanoic acid, ethyl ester (11); | |||||||
didecyl phthalate (12); | |||||||
(Z,Z,Z)-1,4,6,9-nonadecatetraene (13); | |||||||
squalene (14) | |||||||
Stem | Tetradecanoic acid, ethyl ester; | [13][14][27,28] | |||||
pentadecanoic acid, 2,6,10,14- tetramethyl methyl ester (15); |
|||||||
linolenic acid, methyl ester; | |||||||
(E)-11-hexadecenoic acid, ethyl ester; | |||||||
octadecanoic acid, ethyl ester; | |||||||
(Z,Z,Z)-1,4,6,9-nonadecatetraene | |||||||
azobenzene, 4,4′-dibromo- (16); | |||||||
squalene | |||||||
oleic acid (17) | |||||||
Cholestan-3-ol, 2-methylene-(3β,5α)- (18); | |||||||
Leaf | Tetradecanoic acid, ethyl ester | [13][14][27,28] | |||||
3,7,11,15-tetramethyl-2-hexadecen-1-ol (19); | |||||||
Oxirane, tetradecyl- (20); | |||||||
(E)-11-hexadecenoic acid, ethyl ester | |||||||
Hexadecanoic acid, ethyl ester | |||||||
Phytol (21); | |||||||
(Z,Z) 6,9 pentadecadien-1-ol (22); | |||||||
(Z,Z) 9,12-octadecadienoic acid (23); | |||||||
octadecanoic acid, ethyl ester; | |||||||
squalene | |||||||
Leaf | Flavonoids, glycosides, triterpenes, alkaloids, tannins, saponins, phlobatannins | [13][14][27,28] | |||||
Malachra fasciata Jacq. | Leaf | Aurantiamide acetate (24) | [15][29] | ||||
Leaf | 1,3-Diacylglycerol (25) 1,2-Diacylglycerol (26) |
[16][30] |
Malachra Species | Plant Part Used | Extract/Compounds | Pharmacological Activity | Concentration | Method | Major Findings | Reference |
---|---|---|---|---|---|---|---|
M. alceifolia Jacq. | Leaf | Ethanolic | Antiplasmodial | 10 µg/mL | In vitro Plasmodium falciparumIn vitro Plasmodium falciparum 152.2 ± 28.6 nM 152.2Chloroquine ± 28.6 nM Chloroquine controlcontrol |
Inhibitory activity on P. falciparum ferriprotoporphyrin biomineralization inhibition |
[28][29][31,32] |
Shoot | Ethanolic | Antiplasmodial | 77 µg/mL | In vitro Plasmodium falciparumIn vitro Plasmodium falciparum (3D7) chloroquine (3D7concentration no report) chloroquine (concentration no report) |
Inhibitory activity on P. falciparum |
[30][33] | |
M. capitata (L.) L. |
Leaf | Ethanolic | Antibacterial | 62.5 ppm | In vitro MIC |
Inhibition of the growth of Propionibacterium acnes (ATCC 6919) |
[31][71] |
Shoot | Aqueous | Antidiarrhoeal | 200 and 400 mg/kg | In vivoIn vivo oral administration to Wistar rats; castoral administration t oil-induced diarrhoea, enteropooling, and small intestinal transit; 5 mL/kg, p.o diphenoxlate contro Wistar rats; castor oil-induced diarrhoea, enteropooling, and small intestinal transit; 5 mL/kg, p.o diphenoxlate controll |
Decreases intestinal transit | [32][72] | |
Aqueous | Anti-epileptic | 250 and 500 mg/kg | In vivoIn vivo maximal electroshock (MES) and pentylenetetrazole (PTZ)-induced seizuresmodels in albino Wistar rats, maximal electroshock (MES) and pentylenetetrazole (PTZ)-induced seizuresmodels in albino Wistar rats, pentylenetetrazol control control |
Anticonvulsant activity against MES and PTZ animal models | [32][72] | ||
Aqueous | Anti-ulcerogenic | 200 mg/kg y 400 mg/kg | In vivo oral administration to Wistar rats pylorus ligated model, 50mg/kg, p.o ranitidine controlAdministración oral in vivo a ratas Wistar modelo con ligadura de píloro, 50 mg/kg, control de po ranitidina |
Reducir la se the gacreción de ácido gástric acid secretion of pyloruso del píloro. |
[33][ 72 ] | ||
Aqcueouoso | Aantioxidante | 200 y 400 mg/kg | In vivo oral administration to Wistar ratsAdministración oral in vivo a | ||||
Malachra fasciata | |||||||
Jacq. | LeHojaf | Chloroformo/ Acetato de aurantiamide acetate a |
Aantibacterialmicrobiano | 80 µmicrogramos | In vitro MIC CIM in vitro |
Inhibitcion of thón del crecimiento de growth of P. aeruginosa, B. subtilis, P. aeruginosa, B. subtilis, C. albicansC. albicans , |
[21][ 29 ] |
LeHojaf | UDesconknocidown | PhFototoóxic (photosensitization) o (fotosensibilización) |
UDesconknocidown | In vivo sheep females and maleOvejas hembras y machos in vivo |
Causa de offotodermatitis primary photodermatitis in sheep ingestion leafia en ovejas por ingestión de hoja |
[38][ 77 ] | |
LeHojaf | Chloroformo | Antifuúngalico | 30 µg | In vitro MICCIM in vitro |
Inhibitcion of thón del crecimiento de growth of Aspergillus nigerAspergillus niger |
[21][ 29 ] | |
LeHojaf | -(-)loliolidea | Antimutageénico | 8 mg/kg | In vitro micronucleus test induced using mitomycin C, 32% Prueba de micronúcleos in vitro inducida con mitomicina C, 32% |
Reducir e the number of micronucleated polychromatic erythrocytes (MPCE)l número de eritrocitos policromáticos micronucleados (MPCE) |
[22][ 30 ] |